Sales and Marketing

Showing 15 posts of 11520 posts found.

Reaching new heights in branding

February 15, 2006 Sales and Marketing

The pharma industry has come a long way from the days when it believed that products were all about safety …

Abbott suspended from ABPI over sleaze

February 10, 2006 Sales and Marketing ethics

All expenses paid trips for doctors to see greyhound racing, visits to Wimbledon centre court and even a lap dancing …

More Tamiflu released for UK areas hit by seasonal flu

February 10, 2006 Sales and Marketing

Extra supplies of anti-viral treatment Tamiflu are to be made available in areas of the UK suffering from high levels …

GSK looks ahead to surge of products in 2006

February 10, 2006 Sales and Marketing

GlaxoSmithKline has unveiled strong growth in sales and earnings in 2005, and is preparing for a series of key filings, …

Pfizer considers sale of OTC division

February 8, 2006 Sales and Marketing

Pfizer says it is considering selling off its consumer medicines division as part of a new drive to improve flagging …

Big drop in animal rights attacks

January 31, 2006 Sales and Marketing

The number of attacks by animal rights extremists saw a significant fall in 2005, with new laws introduced during the …

Europe approves first ever biotech generic

January 30, 2006 Sales and Marketing

Europe's medicines regulator has approved Sandoz's Omnitrope, the world's first generic equivalent or 'biosimilar' of an existing biotech drug.Patents on …

Merck battling more lawsuits over Vioxx

January 27, 2006 Sales and Marketing

Merck says that it will conduct a vigorous defence in the lawsuit brought by the family of Leonel Garza, who …

Limited access to Alzheimer’s drugs leaves patients groups dissatisfied

January 25, 2006 Sales and Marketing

Patient groups have expressed disappointment at NICE plans to allow only some patients with Alzheimer's disease to have drug treatment, …

Wyeth submits follow-up to antidepressant blockbuster

January 20, 2006 Sales and Marketing

Wyeth has submitted its new antidepressant desvenlafaxine to the FDA, a drug it hopes will be a successor to its …

Next generation hypertension drug ready for 2006 filing

January 20, 2006 Sales and Marketing

Next generation hypertension drug aliskiren is on track for filing in late 2006 and is showing promising results in the …

Novartis to appeal Zelnorm rejection

January 18, 2006 Sales and Marketing

Novartis says it will appeal against an EMEA decision not to recommend its irritable bowel syndrome drug Zelnorm. Zelnorm (tegaserod) …

Prescribers ready to defy NICE in Alzheimer’s drug row

January 18, 2006 Sales and Marketing

Patient groups and manufacturers are hoping NICE will reverse its decision to deny access to Alzheimer's drugs on the NHS, …

First-in-class indication expected for Remicade

January 18, 2006 Sales and Marketing

Schering-Plough expects its arthritis treatment Remicade to receive European approval to treat ulcerative colitis in early 2006.If approved Remicade (infliximab) …

Merck in race to bring first cervical cancer vaccine to market

January 18, 2006 Sales and Marketing

Merck and GlaxoSmithKline are head-to-head in a race to establish a market for their rival cervical cancer vaccines, both set …
The Gateway to Local Adoption Series

Latest content